Early severe vasomotor menopausal symptoms are associated with diabetes

被引:2
|
作者
Herber-Gast, Gerrie-Cor M. [1 ]
Mishra, Gita D. [1 ]
机构
[1] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia
基金
英国医学研究理事会;
关键词
Diabetes; Epidemiology; Hot flushes; Menopause; Night sweats; WOMENS HEALTH; POSTMENOPAUSAL WOMEN; HOT FLASHES; INSULIN-RESISTANCE; RISK-FACTORS; NATION; MIDLIFE; COHORT; TRANSITION; MELLITUS;
D O I
10.1097/gme.0000000000000171
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: The purpose of this study was to investigate associations between profiles of vasomotor menopausal symptoms (VMS) during the menopausal transition with the prevalence of diabetes. Methods: VMS and diabetes were measured at baseline and 3-year intervals for 15 years in 4,895 women in the Australian Longitudinal Study on Women's Health who were aged 45 to 50 years at baseline in 1996. Latent class analysis and generalized estimating equation models for binary repeated measures were performed. The VMS profiles were labeled as mild, moderate, early severe, and late severe. Results: The prevalence of diabetes in the total group was 9.0%. Compared with mild VMS, the odds of diabetes were higher in those with a late severe profile (though not statistically significant; adjusted odds ratio, 1.28; 95% CI, 0.97-1.68) and in those with an early severe profile (adjusted odds ratio, 1.67; 95% CI, 1.20-2.32). Adjustment for body mass index attenuated this association, but the odds of diabetes were still significantly higher in women with an early severe profile than in women with mild VMS (odds ratio, 1.55; 95% CI, 1.11-2.17). The moderate profile was not associated with diabetes. Conclusions: Women with an early severe VMS profile are more likely to have diabetes across a period of 15 years. This association is not explained by body mass index or other potential confounders. Our findings imply that the predictive value of VMS for diabetes may vary with the timing of VMS relative to menopause.
引用
收藏
页码:855 / 860
页数:6
相关论文
共 50 条
  • [11] Effect of desvenlafaxine on mood and climacteric symptoms in menopausal women with moderate to severe vasomotor symptoms
    Cheng, R. J.
    DuPont, C.
    Archer, D. F.
    Bao, W.
    Racketa, J.
    Constantine, G.
    Pickar, J. H.
    CLIMACTERIC, 2013, 16 (01) : 17 - 27
  • [12] Nonhormonal Therapies for Menopausal Vasomotor Symptoms
    Christ, Jacob P.
    Navarro, Victor M.
    Reed, Susan D.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (13): : 1278 - 1279
  • [13] Menopausal vasomotor symptoms and insulin resistance
    Emily D. Szmuilowicz
    Nature Reviews Endocrinology, 2012, 8 : 701 - 702
  • [14] Fezolinetant (Veozah) for Menopausal Vasomotor Symptoms
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2023, 65 (1679): : 97 - 99
  • [15] Menopausal vasomotor symptoms and cardiovascular disease
    Szmuilowicz, Emily D.
    Manson, JoAnn E.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (04): : 345 - 347
  • [16] Role of gabapantin in menopausal vasomotor symptoms
    Singhal, Savita R.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2014, 21 (12): : 1363 - 1363
  • [17] Phytoestrogens for vasomotor menopausal symptoms - Commentary
    不详
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (03): : 769 - 769
  • [18] Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease
    Gast, Gerrie-Cor M.
    Pop, Victor J. M.
    Samsioe, Goran N.
    Grobbee, Diederick E.
    Nilsson, Peter M.
    Keyzer, Jules J.
    Wijnands-van Gent, Colette J. M.
    van der Schouw, Yvonne T.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2011, 18 (02): : 146 - 151
  • [20] Moderate-Severe Vasomotor Symptoms Are Associated with Moderate-Severe Depressive Symptoms
    Worsley, Roisin
    Bell, Robin J.
    Gartoulla, Pragya
    Robinson, Penelope J.
    Davis, Susan R.
    JOURNAL OF WOMENS HEALTH, 2017, 26 (07) : 712 - 718